diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/DM2014175-80diaendo-6310Research ArticleДиагностика, контроль, лечениеDiagnosis, control, treatmentГипогликемии у пожилых больных сахарным диабетом 2 типа, получающих инсулин: результаты непрерывного мониторирования глюкозыHypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoringКлимонтовВадим ВалерьевичKlimontovVadim Valer'evich

доктор медицинских наук, заведующий лабораторией эндокринологии

MD, PhD, Hed of the Endocrinology laboratory

klimontov@mail.ruЦиберкинАлександр ИвановичTsiberkinAlexander Ivanovich

лаборант-исследователь лаборатории эндокринологии

Assistant, Endocrinology laboratory

klimontov@mail.ruФазуллинаОльга НиколаевнаFazullinaOlga Nikolaevna

младший научный сотрудник лаборатории эндокринологии

Junior Researcher, Endocrinology laboratory

klimontov@mail.ruПрудниковаМарина АлексеевнаPrudnikovaMarina Alekseevna

младший научный сотрудник лаборатории эндокринологии

Junior Researcher, Endocrinology laboratory

klimontov@mail.ruТянНадежда ВикторовнаTyanNadezhda Viktorovna

младший научный сотрудник лаборатории эндокринологии

Junior Researcher, Endocrinology laboratory

klimontov@mail.ruКоненковВладимир ИосифовичKonenkovVladimir Iosifovich

академик РАМН, доктор медицинских нак, профессор, директор ФГБУ НИИ клинической и экспериментальной лимфологии СО РАМН

MD, PhD, Professor, fellow of russian Academy of Sciences, Head of Institute

klimontov@mail.ruФГБУ НИИ клинической и экспериментальной лимфологии СО РАМН, НовосибирскРоссияInstitute of Clinical and Experimental Lymphology, NovosibirskRussian Federation2014290320141712014 №17580Copyright © Климонтов В.В., Циберкин А.И., Фазуллина О.Н., Прудникова М.А., Тян Н.В., Коненков В.И., 20142014Климонтов В.В., Циберкин А.И., Фазуллина О.Н., Прудникова М.А., Тян Н.В., Коненков В.И.Klimontov V.V., Tsiberkin A.I., Fazullina O.N., Prudnikova M.A., Tyan N.V., Konenkov V.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/6310сахарный диабет 2 типапожилыегипогликемиинепрерывное мониторирование гликемииинсулинtype 2 diabetes mellituselderlyhypoglycemiacontinuous glucose monitoringinsulinReferencesCryer PE. The barrier of hypoglycemia in diabetes.. Diabetes 2008;57(12):3169-3176. Available from: http://diabetes.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=19033403 PubMed PMID: 19033403. doi: 10.2337/db08-1084.Cryer PE. The barrier of hypoglycemia in diabetes.. Diabetes 2008;57(12):3169-3176. Available from: http://diabetes.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=19033403 PubMed PMID: 19033403. doi: 10.2337/db08-1084.Seaquist ER, AndersonJ, ChildsB, CryerP, Dagogo-JackS, FishL , et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. DiabetesCare 2013;36(5):1384-1395. doi: 10.2337/dc12-2480.Seaquist ER, AndersonJ, ChildsB, CryerP, Dagogo-JackS, FishL , et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. DiabetesCare 2013;36(5):1384-1395. doi: 10.2337/dc12-2480.KlonoffDC, BuckinghamB, ChristiansenJS, MontoriVM, TamborlaneWV, VigerskyRA , et al. Continuous glucose monitoring: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism 2011;96(10):2968-2979. doi: 10.1210/jc.2010-2756.KlonoffDC, BuckinghamB, ChristiansenJS, MontoriVM, TamborlaneWV, VigerskyRA , et al. Continuous glucose monitoring: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism 2011;96(10):2968-2979. doi: 10.1210/jc.2010-2756.Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008;94(3):709-728. Available from: http://www.nlm.nih.gov/medlineplus/hypoglycemia.html PubMed PMID: 19088155. doi: 10.1210/jc.2008-1410.Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008;94(3):709-728. Available from: http://www.nlm.nih.gov/medlineplus/hypoglycemia.html PubMed PMID: 19088155. doi: 10.1210/jc.2008-1410.Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013;36(5):1384-1395. Available from: http://www.nlm.nih.gov/medlineplus/diabetes.html PubMed PMID: 23589542. doi: 10.2337/dc12-2480.Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013;36(5):1384-1395. Available from: http://www.nlm.nih.gov/medlineplus/diabetes.html PubMed PMID: 23589542. doi: 10.2337/dc12-2480.Miller ME, Bonds DE, Gerstein HC, Seaquist ER, Bergenstal RM, Calles-Escandon J, et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010;340. Available from: http://www.bmj.com/cgi/pmidlookup?view=long&pmid=20061360 PubMed PMID: 20061360.Miller ME, Bonds DE, Gerstein HC, Seaquist ER, Bergenstal RM, Calles-Escandon J, et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010;340. Available from: http://www.bmj.com/cgi/pmidlookup?view=long&pmid=20061360 PubMed PMID: 20061360.Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, et al. Severe Hypoglycemia and Risks of Vascular Events and Death. N Engl J Med 2010;363(15):1410-1418. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa1003795 PubMed PMID: 20925543. doi: 10.1056/NEJMoa1003795.Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, et al. Severe Hypoglycemia and Risks of Vascular Events and Death. N Engl J Med 2010;363(15):1410-1418. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa1003795 PubMed PMID: 20925543. doi: 10.1056/NEJMoa1003795.Shorr RI. Incidence and Risk Factors for Serious Hypoglycemia in Older Persons Using Insulin or Sulfonylureas. Arch Intern Med 1997;157(15):1681-1686. Available from: http://archinte.jamanetwork.com/article.aspx?doi=10.1001/archinte.1997.00440360095010 PubMed PMID: 9250229. doi: 10.1001/archinte.1997.00440360095010.Shorr RI. Incidence and Risk Factors for Serious Hypoglycemia in Older Persons Using Insulin or Sulfonylureas. Arch Intern Med 1997;157(15):1681-1686. Available from: http://archinte.jamanetwork.com/article.aspx?doi=10.1001/archinte.1997.00440360095010 PubMed PMID: 9250229. doi: 10.1001/archinte.1997.00440360095010.Davis TME, Brown SGA, Jacobs IG, Bulsara M, Bruce DG, Davis WA. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. J Clin Endocrinol Metab 2010;95(5):2240-2247. Available from: http://www.nlm.nih.gov/medlineplus/diabetestype2.html PubMed PMID: 20305006. doi: 10.1210/jc.2009-2828.Davis TME, Brown SGA, Jacobs IG, Bulsara M, Bruce DG, Davis WA. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. J Clin Endocrinol Metab 2010;95(5):2240-2247. Available from: http://www.nlm.nih.gov/medlineplus/diabetestype2.html PubMed PMID: 20305006. doi: 10.1210/jc.2009-2828.Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50(6):1140-1147. Available from: http://www.nlm.nih.gov/medlineplus/diabetesmedicines.html PubMed PMID: 17415551. doi: 10.1007/s00125-007-0599-y.Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50(6):1140-1147. Available from: http://www.nlm.nih.gov/medlineplus/diabetesmedicines.html PubMed PMID: 17415551. doi: 10.1007/s00125-007-0599-y.Monnier L, Wojtusciszyn A, Colette C, Owens D. The Contribution of Glucose Variability to Asymptomatic Hypoglycemia in Persons with Type 2 Diabetes. Diabetes Technology & Therapeutics 2011;13(8):813-818. Available from: http://online.liebertpub.com/doi/abs/10.1089/dia.2011.0049 PubMed PMID: 21561372. doi: 10.1089/dia.2011.0049.Monnier L, Wojtusciszyn A, Colette C, Owens D. The Contribution of Glucose Variability to Asymptomatic Hypoglycemia in Persons with Type 2 Diabetes. Diabetes Technology & Therapeutics 2011;13(8):813-818. Available from: http://online.liebertpub.com/doi/abs/10.1089/dia.2011.0049 PubMed PMID: 21561372. doi: 10.1089/dia.2011.0049.Qu Y, Jacober SJ, Zhang Q, Wolka LL, DeVries, J. Hans . Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability Data. Diabetes Technology and Therapeutics 2012;14(11):1008-1012. Available from: http://online.liebertpub.com/doi/abs/10.1089/dia.2012.0099 PubMed PMID: 23101951. doi: 10.1089/dia.2012.0099.Qu Y, Jacober SJ, Zhang Q, Wolka LL, DeVries, J. Hans . Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability Data. Diabetes Technology and Therapeutics 2012;14(11):1008-1012. Available from: http://online.liebertpub.com/doi/abs/10.1089/dia.2012.0099 PubMed PMID: 23101951. doi: 10.1089/dia.2012.0099.Dailey GE, Gao L, Aurand L, Garg SK. Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulinglargine or NPH insulin. Diabetes, Obesity and Metabolism 2013;15(12):1082-1085. doi: 10.1111/dom.1213.Dailey GE, Gao L, Aurand L, Garg SK. Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulinglargine or NPH insulin. Diabetes, Obesity and Metabolism 2013;15(12):1082-1085. doi: 10.1111/dom.1213.Akram K, Pedersen-Bjergaard U, Carstensen B, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet Med 2006;23(7):750-756. Available from: http://www.scholaruniverse.com/ncbi-linkout?id=16842479 PubMed PMID: 16842479. doi: 10.1111/j.1464-5491.2006.01880.x.Akram K, Pedersen-Bjergaard U, Carstensen B, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet Med 2006;23(7):750-756. Available from: http://www.scholaruniverse.com/ncbi-linkout?id=16842479 PubMed PMID: 16842479. doi: 10.1111/j.1464-5491.2006.01880.x.Engler B, Koehler C, Hoffmann C, Landgraf W, Bilz S, Schoner C, et al. Relationship between HbA1c on target, risk of silent hypoglycemia and glycemic variability in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2011;119(1):59-61. Available from: http://www.nlm.nih.gov/medlineplus/bloodsugar.html PubMed PMID: 21246466. doi: 10.1055/s-0030-1262874.Engler B, Koehler C, Hoffmann C, Landgraf W, Bilz S, Schoner C, et al. Relationship between HbA1c on target, risk of silent hypoglycemia and glycemic variability in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2011;119(1):59-61. Available from: http://www.nlm.nih.gov/medlineplus/bloodsugar.html PubMed PMID: 21246466. doi: 10.1055/s-0030-1262874.Berlin I, Sachon CI, Grimaldi A. Identification of factors associated with impaired hypoglycaemia awareness in patients with type 1 and type 2 diabetes mellitus. Diabetes Metab 2005;31(3 Pt 1):246-251. Available from: http://www.masson.fr/masson/MDOI-DM-06-2005-31-3-1262-3636-101019-200514506 PubMed PMID: 16142015. doi: DM-06-2005-31-3-1262-3636-101019-200514506.Berlin I, Sachon CI, Grimaldi A. Identification of factors associated with impaired hypoglycaemia awareness in patients with type 1 and type 2 diabetes mellitus. Diabetes Metab 2005;31(3 Pt 1):246-251. Available from: http://www.masson.fr/masson/MDOI-DM-06-2005-31-3-1262-3636-101019-200514506 PubMed PMID: 16142015. doi: DM-06-2005-31-3-1262-3636-101019-200514506.Bremer JP, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care 2009;32(8):1513-1517. Available from: http://europepmc.org/abstract/MED/19487634 PubMed PMID: 19487634. doi: 10.2337/dc09-0114.Bremer JP, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care 2009;32(8):1513-1517. Available from: http://europepmc.org/abstract/MED/19487634 PubMed PMID: 19487634. doi: 10.2337/dc09-0114.Hermanides J, Phillip M, DeVries JH. Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes: Pros and cons. Diabetes Care 2011;34(Supplement 2). PubMed PMID: 21525455. doi: 10.2337/dc11-s219.Hermanides J, Phillip M, DeVries JH. Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes: Pros and cons. Diabetes Care 2011;34(Supplement 2). PubMed PMID: 21525455. doi: 10.2337/dc11-s219.Rebrin K, Steil GM. Can interstitial glucose assessment replace blood glucose measurements?. Diabetes Technol Ther 2000;2(3):461-472. Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+50-99-7 PubMed PMID: 11467349. doi: 10.1089/15209150050194332.Rebrin K, Steil GM. Can interstitial glucose assessment replace blood glucose measurements?. Diabetes Technol Ther 2000;2(3):461-472. Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+50-99-7 PubMed PMID: 11467349. doi: 10.1089/15209150050194332.Choudhary P, Lonnen K, Emery CJ, Freeman JV, McLeod KM, Heller SR. Relationship Between Interstitial and Blood Glucose During Hypoglycemia in Subjects with Type 2 Diabetes. Diabetes Technology and Therapeutics 2011;13(11):1121-1127. Available from: http://online.liebertpub.com/doi/abs/10.1089/dia.2011.0059 doi: 10.1089/dia.2011.0059.Choudhary P, Lonnen K, Emery CJ, Freeman JV, McLeod KM, Heller SR. Relationship Between Interstitial and Blood Glucose During Hypoglycemia in Subjects with Type 2 Diabetes. Diabetes Technology and Therapeutics 2011;13(11):1121-1127. Available from: http://online.liebertpub.com/doi/abs/10.1089/dia.2011.0059 doi: 10.1089/dia.2011.0059.Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ;2010(340):4909. doi: 10.1136/bmj.b4909Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ;2010(340):4909. doi: 10.1136/bmj.b4909Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. N Engl J Med 2009;360(2):129-139. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa0808431 PubMed PMID: 19092145. doi: 10.1056/NEJMoa0808431.Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. N Engl J Med 2009;360(2):129-139. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa0808431 PubMed PMID: 19092145. doi: 10.1056/NEJMoa0808431.Landstedt-Hallin L, Englund A, Adamson U, Lins PE. Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus. J Intern Med 1999;246(3):299-307. Available from: http://www.nlm.nih.gov/medlineplus/arrhythmia.html PubMed PMID: 10475998. doi: -2796.1999.00528.x.Landstedt-Hallin L, Englund A, Adamson U, Lins PE. Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus. J Intern Med 1999;246(3):299-307. Available from: http://www.nlm.nih.gov/medlineplus/arrhythmia.html PubMed PMID: 10475998. doi: -2796.1999.00528.x.Torimoto K, Okada Y, Mori H, Tanaka Y. Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol 2013;12:1. Available from: http://www.cardiab.com/content/12//1 PubMed PMID: 23280391. doi: 10.1186/1475-2840-12-1.Torimoto K, Okada Y, Mori H, Tanaka Y. Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol 2013;12:1. Available from: http://www.cardiab.com/content/12//1 PubMed PMID: 23280391. doi: 10.1186/1475-2840-12-1.Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V. Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring. Diabetes Care 2003;26(5):1485-1489. Available from: http://dx.doi.org/10.2337/diacare.26.5.1485 PubMed PMID: 12716809. doi: 10.2337/diacare.26.5.1485.Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V. Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring. Diabetes Care 2003;26(5):1485-1489. Available from: http://dx.doi.org/10.2337/diacare.26.5.1485 PubMed PMID: 12716809. doi: 10.2337/diacare.26.5.1485.Дедов ИИ, Шестакова МВ, Аметов АС, Анциферов МБ, Галстян ГР, Майоров АЮ, Мкртумян АМ, Петунина НА, Сухарева ОЮ. Консенсус совета экспертов Российской ассоциации эндокринологов по инициации и интенсификации сахароснижающей терапии у больных сахарным диабетом 2 типа. Сахарный диабет. 2011;(4):6-17. [Dedov I.I., Shestakova M.V., Ametov A.S., Antsiferov M.B., Galstyan G.R., Mayorov A.Y., Mkrtumyan A.M., Petunina N.A., Sukhareva O.Y. Diabetes mellitus Russian Association of Endocrinologists expert consensus document on initiation and intensification of antyhyperglycaemic therapy in type 2 diabetes mellitus. Diabetes mellitus.2011;(4):6-17.] DOI: http://dx.doi.org/10.14341/2072-0351-5810Дедов ИИ, Шестакова МВ, Аметов АС, Анциферов МБ, Галстян ГР, Майоров АЮ, Мкртумян АМ, Петунина НА, Сухарева ОЮ. Консенсус совета экспертов Российской ассоциации эндокринологов по инициации и интенсификации сахароснижающей терапии у больных сахарным диабетом 2 типа. Сахарный диабет. 2011;(4):6-17. [Dedov I.I., Shestakova M.V., Ametov A.S., Antsiferov M.B., Galstyan G.R., Mayorov A.Y., Mkrtumyan A.M., Petunina N.A., Sukhareva O.Y. Diabetes mellitus Russian Association of Endocrinologists expert consensus document on initiation and intensification of antyhyperglycaemic therapy in type 2 diabetes mellitus. Diabetes mellitus.2011;(4):6-17.] DOI: http://dx.doi.org/10.14341/2072-0351-5810Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD. Diabetes Care 2012;35(6):1364-1379. doi: 10.2337/dc12-0413.Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD. Diabetes Care 2012;35(6):1364-1379. doi: 10.2337/dc12-0413.

The authors declare that there are no conflicts of interest present.